Six institutions, including the University of Pennsylvania, are joining forces to develop cancer immunotherapies through a new research institute launched this week with a $250 million grant from Napster founder Sean Parker.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.